---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042874"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:05:17.895419+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Qualigen Therapeutics Stockholders Approve Reverse Stock Split and Share Issuance to Alpha Capital at Annual Meeting

## Summary
- All five director nominees elected, each receiving over 14.3 million votes.
- Ratification of WithumSmith+Brown as auditor approved with 17,030,627 votes in favor.
- Reverse stock split (10:1 to 50:1) approved with 16,165,754 votes for, 1,435,884 against.
- Issuance of >20% common stock to Alpha Capital Anstalt approved with 14,562,299 votes for, 347,563 against, 18,595 abstaining.
- Advisory vote on executive compensation approved with 14,540,812 votes for, 297,422 against, 90,223 abstaining.

## SEC filing metadata
- accession: 0001493152-24-042874
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315224042874/0001493152-24-042874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315224042874/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042874
- JSON: https://secwatch.observer/filing/0001493152-24-042874.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042874.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.